LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 26 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,582,000 | -5.7% | 3,090,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,857,000 | -12.0% | 3,090,000 | +0.1% | 0.00% | 0.0% |
| Q4 2018 | $5,519,000 | -49.9% | 3,087,000 | +1.5% | 0.00% | -50.0% |
| Q3 2018 | $11,008,000 | +312.3% | 3,041,000 | +193.5% | 0.00% | +100.0% |
| Q2 2018 | $2,670,000 | -57.5% | 1,036,000 | -63.9% | 0.00% | 0.0% |
| Q1 2018 | $6,279,000 | +251.2% | 2,873,000 | +197.4% | 0.00% | – |
| Q4 2017 | $1,788,000 | +395.3% | 966,000 | +383.0% | 0.00% | – |
| Q3 2017 | $361,000 | -89.2% | 200,000 | -90.0% | 0.00% | -100.0% |
| Q2 2017 | $3,339,000 | +131.9% | 2,000,000 | +108.3% | 0.00% | – |
| Q1 2017 | $1,440,000 | +97.5% | 960,000 | +92.0% | 0.00% | – |
| Q3 2016 | $729,000 | -57.7% | 500,000 | -51.0% | 0.00% | – |
| Q2 2016 | $1,725,000 | -71.0% | 1,020,000 | -74.6% | 0.00% | -100.0% |
| Q1 2016 | $5,951,000 | -28.7% | 4,020,000 | -25.0% | 0.00% | 0.0% |
| Q4 2015 | $8,351,000 | +23.4% | 5,360,000 | +4.1% | 0.00% | 0.0% |
| Q3 2015 | $6,765,000 | – | 5,150,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|